Breaks Categories: News

ThursdayMay 05, 2022 11:53 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science Inc.’s Radicle Energy rare cannabinoid study to assess the effects of delta-9 (“d-9”) dominant tetrahydrocannabivarin (“THCV”) on energy, focus/attention, appetite and weight/BMI. According to the update, BayMedia will be supplying its highly pure d-9 dominant THCV, formulated into a proprietary lozenge manufactured by Trokie. “We are excited to be part of this groundbreaking study with Trokie and Radicle Science in advance of our commercial launch…

Continue Reading

WednesdayMay 04, 2022 3:06 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Executes on Collaborative Cannabis Cultivation Model

Sugarmade (OTC: SGMD), an emerging company in the licensed cannabis sector, today announced its first transaction relative to its collaborative cannabis cultivation strategy via a definitive and executed contract with Cannabis Global Inc. (OTC: CBGL). Under the agreement, Sugarmade, via partner licensed and permitted Lake County, California, cannabis cultivators, will produce approximately 25,000 pounds of “Fresh Frozen” cannabis, which Cannabis Global will use in its product lines and distribute to the California marketplace. “As we recently announced to our shareholders, we see a strong business model of utilizing now idle resources of other California cultivators who have decided they can…

Continue Reading

WednesdayMay 04, 2022 1:50 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Launches New Skincare Line Ahead of Luxury Meets Cannabis Conference

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the launch of a new skincare line under its brand, MIND Naturals (“Mind”), ahead of the Luxury Meets Cannabis Conference (“LMCC”) in New York City. Mind is inspired by its Colombian roots and leverages superfruits and nutrients native to Colombia for its new non-CBD line of skincare products. “This is a very exciting launch from MIND Naturals and Flora - the U.S. skincare market alone presents a unique opportunity for growing all-natural skincare brands, with annual revenue of approximately $17.6 billion,” said Flora…

Continue Reading

WednesdayMay 04, 2022 1:36 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Transition from Pure-Play Pharma R&D Firm Featured in Research Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, was featured in a report published by Edison Group, a leading research and investor relations consultancy. The piece details InMed Pharmaceuticals and its continued “transition from a pure-play pharma R&D firm to one also benefiting from commercial sales into the health and wellness market. Product launches of high-value, rare cannabinoids into this market should provide the majority of its revenue in the near future,” the report reads. “INM also made notable advances in its pharmaceutical drug development programs, including its ongoing 755-201-EB Phase II…

Continue Reading

TuesdayMay 03, 2022 2:30 pm

CannabisNewsBreaks – Organa Kannalytics’ SHMC Event to Shine the Spotlight on Medical Use, Practices and Opportunities in the Hemp and Cannabis Space

Organa Kannalytics, an advocacy organization seeking to bring legitimacy to the hemp and medical cannabis industry through science and education, today announced the 2022 Southeastern Hemp and Medical Cannabis (“SHMC”) Convention and Expo will be held May 12-14, 2022. The event will take place live at the Cobb Galleria Centre in Atlanta, Georgia, as well as virtually via livestream. The multi-day SHMC expo will offer networking opportunities and break-out sessions covering medical use and practices and business opportunities in the hemp and cannabis space. “We’re excited to offer people from all over the country in the cannabis space a place…

Continue Reading

TuesdayMay 03, 2022 2:08 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) GrowPods Viable Solution for Food Shortages

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies, has reported that these modular hydroponic greenhouses can help reduce global food shortage. The GrowPods can be set up almost anywhere in the world and can help feed local populations. Food shortage is a relevant topic because of the food shortages caused by the war in Ukraine. The country has been called the “breadbasket” of the world because it grows enough food, particularly wheat, to feed an estimated 400 million people. According to experts, the war is already…

Continue Reading

MondayMay 02, 2022 1:47 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Shares Corporate Update through Shareholder Letter

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, has released a shareholder letter from CEO Jimmy Chan. In the letter, Chan noted short-term turbulence in the market but reaffirmed the company’s belief that the long-term outlook for the industry is bright, particularly for California producers and distributors. The letter notes that the company is eyeing strategic opportunities created by marketplace inefficiencies and uncertainties, including an uncertain regulatory environment, high taxes, unlicensed cultivators entering the market and a drop in prices of cultivated cannabis products. In the letter, Chan observed that Sugarmade believes these marketplace changes create an…

Continue Reading

FridayApr 29, 2022 1:17 pm

CannabisNewsBreaks – Vantage Hemp Company Announces Submission of DMF, Reinforces Commitment to Deliver Superior API Quality

Vantage Hemp has submitted a Drug Master File (“DMF”) to the U.S. Food & Drug Administration (“FDA”) covering its hemp-derived cannabidiol (“CBD”) distillate. According to the announcement, the submission further reinforces Vantage as a transparent, reliable and compliant partner, committed to working with pharmaceutical companies to formulate its CBD active pharmaceutical ingredient (“API”). The filing, which also strengthens Vantage’s position as an industry leader, represents the company’s commitment to support its clients through all phases of drug development. The company also noted that it anticipates filing future DMF submissions as it works to deliver superior API quality. “Our distillate DMF…

Continue Reading

FridayApr 29, 2022 11:00 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Participate in Luxury Meets Cannabis Conference

Flora Growth’s (NASDAQ: FLGC) executives Luis Merchan and James Choe are scheduled to participate at the upcoming Luxury Meets Cannabis Conference. The two-day event is scheduled for May 5–6, 2022, in New York City. The premier B2B CBD, hemp and cannabis event — the first of its kind — is an ideal venue to shine a spotlight on FLGC’s impressive line of lifestyle products and brands. The conference is designed to bring together premium CBD, hemp and cannabis brands and their founders with representatives from top mainstream retailers, global media, leading dispensaries and investors. Flora Growth is a leading all-outdoor cannabis cultivator…

Continue Reading

ThursdayApr 28, 2022 12:50 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the publication of a patent application in North America. The application has broad claims directed to the molecular structure, uses and methods of manufacturing of several cannabinoid analogs. Describing several new cannabinoid-related chemical compounds, the broad patent application, if granted, allows for the creation of several variations of novel cannabinoid compounds, producing a robust library of proprietary new chemical entities (“NCEs”). “We believe rare cannabinoids hold tremendous therapeutic potential that may address a number of unmet medical needs,” said Eric Hsu, SVP,…

Continue Reading